药品名称ZOSYN
申请号050684产品号004
活性成分PIPERACILLIN SODIUM; TAZOBACTAM SODIUM市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL
治疗等效代码AP参比药物
批准日期1993/10/22申请机构WYETH PHARMACEUTICALS INC
化学类型审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
69001842023/04/14YU-282PDF格式
81338832023/04/14YU-282PDF格式
79152292023/04/14YPDF格式
历史专利信息
69001842023/04/14YYU-282PDF格式
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
050684086APLetter2016/06/13下载
050684086APLabel2016/06/13下载
050684084APLetter2016/06/13下载
050684084APLabel2016/06/13下载
050684083APLetter2015/12/22下载
050684083APLabel2015/12/29下载
050684080APLetter2013/09/11下载
050684080APLabel2013/09/09下载
050684074APLabel2013/09/09下载
050684074APLetter2013/09/11下载
050684071APLabel2011/09/30下载
050684071APLetter2011/10/03下载
050684063APLabel2013/09/09下载
050684063APLetter2013/09/11下载
050684061APLetter2012/05/15下载
050684061APLabel2012/05/15下载
050684055APLabel2012/05/15下载
050684052APLetter2008/04/22下载
050684052APLabel2008/06/05下载
050684051APLetter2008/04/22下载
050684051APLabel2008/06/05下载
050684046APLabel2006/07/27下载
050684046APLetter2006/08/04下载
050684045APReview2007/06/11下载
050684045APLabel2005/10/10下载
050684045APLetter2005/10/20下载
050684044APLetter2005/06/29下载
050684039APLetter2005/03/18下载
050684038APLetter2004/02/03下载
050684035APLetter2003/05/30下载
050684035APLabel2003/05/06下载
050684033APLetter2003/05/29下载
050684033APLabel2003/04/30下载
050684015APLetter2002/03/27下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
050684087AP2016/09/07Manufacturing Change or Addition
050684086AP2016/06/10Labeling Revision
050684085AP2016/05/16Manufacturing Change or Addition
050684084AP2016/06/10Labeling Revision
050684083AP2015/12/18Labeling Revision
050684082AP2014/08/05Manufacturing Change or Addition
050684081AP2014/02/25Manufacturing Change or Addition
050684080AP2013/09/06Labeling Revision
050684079AP2013/08/20Manufacturing Change or Addition
050684078AP2013/03/27Manufacturing Change or Addition
050684074AP2013/09/06Labeling Revision
050684071AP2011/09/28Labeling Revision
050684063AP2013/09/06Labeling Revision
050684061AP2012/05/11Labeling Revision
050684055AP2012/05/11Labeling Revision
050684052AP2008/04/17Labeling Revision
050684051AP2008/04/17Labeling Revision
050684046AP2006/07/26Efficacy Supplement with Clinical Data to Support
050684045AP2005/09/30Formulation Revision
050684044AP2005/06/27Labeling Revision
050684039AP2005/03/15Labeling Revision
050684038AP2004/01/30Labeling Revision
050684035AP2003/05/01Labeling Revision
050684033AP2003/04/28New Dosage Regimen
050684032AP2002/12/04Package Change
050684031AP2002/10/10Control Supplement
050684030AP2002/03/15Control Supplement
050684029AP2002/03/15Expiration Date Change
050684028AP2002/03/14Control Supplement
050684027AP2002/02/26Control Supplement
050684026AP2001/12/19Control Supplement
050684023AP2001/08/20Package Change
050684021AP2001/02/01Control Supplement
050684020AP2000/11/22Manufacturing Change or Addition
050684019AP2000/11/21Control Supplement
050684018AP2000/08/01Control Supplement
050684017AP2000/08/01Control Supplement
050684016AP2000/08/01Package Change
050684015AP2002/03/27Labeling Revision
050684013AP1998/07/13Manufacturing Change or Addition
050684012AP1999/03/11Manufacturing Change or Addition
050684011AP1997/07/31Control Supplement
050684010AP1997/06/16Package Change
050684009AP1996/11/18Package Change
050684008AP1996/12/13Control Supplement
050684007AP1995/07/10Control Supplement
050684005AP1994/10/12Control Supplement
050684004AP1994/07/13Labeling Revision
050684003AP1994/08/24Package Change
050684002AP1994/07/13Labeling Revision
050684001AP1996/05/08New or Modified Indication
050684000AP1993/10/22Approval